Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)

Author:

Kopeć GrzegorzORCID,Kurzyna MarcinORCID,Mroczek Ewa,Chrzanowski Łukasz,Mularek-Kubzdela Tatiana,Skoczylas Ilona,Kuśmierczyk Beata,Pruszczyk Piotr,Błaszczak Piotr,Lewicka Ewa,Karasek Danuta,Mizia-Stec Katarzyna,Tomaszewski Michał,Jacheć Wojciech,Ptaszyńska-Kopczyńska Katarzyna,Peregud-Pogorzelska Małgorzata,Doboszyńska Anna,Pawlak AgnieszkaORCID,Gąsior Zbigniew,Zabłocka Wiesława,Ryczek Robert,Widejko-Pietkiewicz Katarzyna,Waligóra Marcin,Darocha Szymon,Furdal Michał,Ciurzyński Michał,Kasprzak Jarosław D.ORCID,Grabka Marek,Kamiński KarolORCID,Hoffman PiotrORCID,Podolec Piotr,Torbicki AdamORCID

Abstract

Current knowledge of pulmonary arterial hypertension (PAH) epidemiology is based mainly on data from Western populations, and therefore we aimed to characterize a large group of Caucasian PAH adults of Central-Eastern European origin. We analyzed data of incident and prevalent PAH adults enrolled in a prospective national registry involving all Polish PAH centers. The estimated prevalence and annual incidence of PAH were 30.8/mln adults and 5.2/mln adults, respectively and they were the highest in females ≥65 years old. The most frequent type of PAH was idiopathic (n = 444; 46%) followed by PAH associated with congenital heart diseases (CHD-PAH, n = 356; 36.7%), and PAH associated with connective tissue disease (CTD-PAH, n = 132; 13.6%). At enrollment, most incident cases (71.9%) were at intermediate mortality risk and the prevalent cases had most of their risk factors in the intermediate or high risk range. The use of triple combination therapy was rare (4.7%). A high prevalence of PAH among older population confirms the changing demographics of PAH found in the Western countries. In contrast, we found: a female predominance across all age groups, a high proportion of patients with CHD-PAH as compared to patients with CTD-PAH and a low use of triple combination therapy.

Publisher

MDPI AG

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3